Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Preparing Cold-Processed Nasal Sprays

Posted on By




SOP for Preparing Cold-Processed Nasal Sprays



Standard Operating Procedure for Preparing Cold-Processed Nasal Sprays

1) Purpose

The purpose of this SOP is to provide the step-by-step procedure for preparing nasal sprays using a cold-processing technique, which helps to maintain the integrity of temperature-sensitive active pharmaceutical ingredients (APIs) and excipients.

2) Scope

This SOP applies to all personnel involved in the preparation, testing, and quality control of cold-processed nasal spray formulations at [Company Name].

3) Responsibilities

  • Operators: Responsible for executing the cold-processing formulation process to ensure the correct handling of temperature-sensitive ingredients.
  • Quality Assurance (QA): Ensures the final product meets the quality and sterility requirements.
  • Maintenance Team: Responsible for the maintenance and calibration of cold-processing equipment.

4) Procedure

4.1 Preparation of Materials

4.1.1 Selection of Ingredients

  • Choose active pharmaceutical ingredients (APIs) and excipients that are temperature-sensitive and require cold processing for optimal stability.
  • Store ingredients in cold storage prior to formulation to prevent degradation. Record the storage conditions in the Batch Manufacturing Record (BMR).

4.1.2 Weighing of Ingredients

  • Weigh APIs and excipients using a calibrated balance, ensuring accuracy within ±2%. Weigh materials in a controlled environment to maintain cold storage requirements.
  • Document the
weighed quantities in the BMR.

4.2 Cold Processing

4.2.1 Preparation of the Aqueous Phase

  • Prepare the aqueous phase by dissolving excipients in cold Water for Injection (WFI) at 2-8°C. Keep the mixing vessel in a chilled environment to maintain temperature.
  • Ensure the solution is free from foam by stirring gently. Maintain the temperature of the aqueous phase throughout the entire process.

4.2.2 Incorporating the API

  • Slowly add the API to the cold aqueous phase while stirring continuously to prevent clumping or aggregation.
  • Use a cold homogenizer to achieve a uniform mixture. Monitor the temperature closely, ensuring it does not exceed 8°C during the entire mixing process.
  • Record the mixing parameters, including time, speed, and temperature, in the BMR.

4.2.3 pH Adjustment

  • Measure the pH using a calibrated pH meter. Adjust the pH as necessary using a cold buffer solution to maintain nasal compatibility (typically pH 5.5-7.0).
  • Record the pH adjustments and the final pH in the BMR.

4.3 Filtration and Sterilization

4.3.1 Cold Sterilization

  • Filter the formulation using a sterile 0.22-micron filter to remove microbial contaminants. Ensure that the filtration is performed under cold conditions (2-8°C).
  • Record the filtration process in the BMR, including the filter integrity test results.

4.4 Filling and Packaging

4.4.1 Filling the Nasal Spray Containers

  • Transfer the sterile formulation to a filling machine pre-calibrated for cold operation. Fill the containers at low temperatures to ensure that the API remains stable throughout the filling process.
  • Check the fill accuracy by weighing 10 filled units. Record the fill weight and ensure it is within ±5% of the target volume.

4.4.2 Sealing and Packaging

  • Seal the filled containers with pre-sterilized nozzles or caps. Store the final product in a temperature-controlled environment (2-8°C) until packaging.
  • Package the nasal sprays in labeled containers, ensuring the labels include cold storage instructions. Record the packaging details in the BMR.

4.5 Quality Control Testing

4.5.1 Stability Testing

  • Conduct stability testing on the cold-processed nasal spray formulation under different temperature conditions to ensure that the product remains stable during storage and transportation.
  • Record all stability test results in the stability testing log.

4.5.2 Microbial Testing

  • Perform microbial testing to ensure sterility of the final product. Record the results in the microbial testing log.

4.6 Documentation

  • Document all steps of the cold-processing, filtration, filling, and packaging in the BMR.
  • Ensure QA reviews and approves all documents before the product is released for distribution.

4.7 Equipment Cleaning and Calibration

4.7.1 Equipment Calibration

  • Calibrate all equipment used in cold-processing, including temperature-controlled vessels, balances, and filling machines. Record calibration data in the calibration log.

4.7.2 Cleaning Equipment

  • Clean all equipment using a validated cold-cleaning procedure to prevent contamination. Record the cleaning process in the cleaning log.

5) Abbreviations, if any

  • API: Active Pharmaceutical Ingredient
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • WFI: Water for Injection

6) Documents, if any

  • Batch Manufacturing Record (BMR)
  • Stability Testing Log
  • Microbial Testing Log
  • Calibration Log
  • Cleaning Log

7) References, if any

  • ICH Q1A – Stability Testing Guidelines
  • FDA Guidance for Nasal Drug Products

8) SOP Version

Version 1.0

Annexure

1. Stability Testing Log Template

Date Formulation Storage Temperature Time Interval Stability Results Operator Initials QA Approval
DD/MM/YYYY Formulation Name Temperature 1 month, 3 months, etc. Pass/Fail Operator Name QA Name
           

2. Microbial Testing Log Template

Date Formulation Microbial Test Results Operator Initials QA Approval
DD/MM/YYYY Formulation Name Microbial Test Results Operator Name QA Name
           

3. Calibration Log Template

Date Equipment ID Calibration Procedure Calibration Results Operator Initials QA Approval
DD/MM/YYYY Equipment Name/ID Procedure Pass/Fail Operator Name QA Name
           

4. Cleaning Log Template

Date Equipment ID Cleaning Procedure Operator Initials QA Approval
DD/MM/YYYY Equipment Name/ID Procedure Operator Name QA Name
           


See also  SOP for Preparation and Sterilization of API and Excipients
Nasal Spray Formulations Tags:Cleaning SOP for nasal spray equipment, Environmental control in nasal spray production, Equipment maintenance for nasal sprays, Formulating isotonic nasal sprays, Microbial stability in nasal formulations, Mixing SOP for nasal formulations, Nasal spray API formulation, Nasal spray batch manufacturing SOP, Nasal spray filling machine operation, Nasal spray formulation process, Nasal spray GMP guidelines, Nasal spray homogenization techniques, Nasal spray manufacturing process, Nasal spray packaging SOP, Nasal spray preservative-free formulation, Nasal spray production SOP, Nasal spray stability studies, Nasal spray sterilization process, Nasal spray viscosity monitoring, Particle size control in nasal sprays, pH adjustment in nasal formulations, Quality control in nasal spray production, Solvent selection for nasal sprays, SOP for nasal spray manufacturing, SOP for nasal spray testing

Post navigation

Previous Post: SOP for Incorporation of Targeting Ligands in Liposome Formulations
Next Post: Nanoparticle Formulation : SOP for Incorporation of Targeting Ligands in Nanoparticle Formulations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version